Novo Nordisk starts phase 1 trial with long-acting oral GLP-1 analogue
- Details
- Category: Novo Nordisk
![Novo Nordisk Novo Nordisk](http://www.worldpharmanews.com/images/stories/logo/novonordisk_b.gif)
FDA approves ACTEMRA for the treatment of moderately to severely active rheumatoid arthritis
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Genzyme Reports Fourth-Quarter Revenue
- Details
- Category: Genzyme
![Genzyme Corp. Genzyme Corp.](http://www.worldpharmanews.com/images/stories/logo/genzyme.gif)
Novartis launches schizophrenia treatment Fanapt in the US
- Details
- Category: Novartis
![Novartis Novartis](http://www.worldpharmanews.com/images/stories/logo/novartis_b.gif)
Abbott's XIENCE V(R) Approved in Japan - Second Largest Drug Eluting Stent Market Worldwide
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
AstraZeneca Reaches Agreements With Teva Pharmaceuticals
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](http://www.worldpharmanews.com/images/stories/logo/astrazeneca_b.gif)
Pfizer and Strides Arcolab to Collaborate on Generic Products
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
More Pharma News ...
- Luitpold Pharmaceuticals, Inc. Acquires PharmaForce, Inc.
- All three Novartis A(H1N1) 2009 influenza vaccines prequalified by World Health Organization
- Pfizer Provides U.S. Regulatory Update On Prevnar 13™ Vaccine
- Sanofi-aventis to Acquire Chattem Inc. Creating a Strong U.S. Consumer Healthcare Platform
- FDA Approves SPIRIVA® HandiHaler® for the Reduction of COPD Exacerbations
- Sanofi Pasteur to Develop & Commercialize Vaccine to Prevent Staphylococcus infections
- GSK publishes speaking, consulting fees paid to US healthcare professionals